Recently added articles from BT Catalyst:
N.C.'s Umstead site homeland security facility finalist.
Jul 01, 2007 ... North Carolina is among the five finalists vying to land the $450 million National Bio and Agro-Defense Facility (NBAF), a prestigious and economy-boosting federal biodefense laboratory to be built to fight diseases such as avian flu and foot-and-mouth disease and bioterrorism agents such ...
BT catalyst to come weekly--via email.
Jul 01, 2007 ... After two decades as the newsletter of record for North Carolina's biotechnology community, BT Catalyst is soon to become "a publication formerly known as print." BT Catalyst will still be our publication of record for biotechnology. But from now on that will be an electronic ...
Board picks Norris Tolson as president, CEO.
Jul 01, 2007 ... NORRIS TOLSON HAS BEEN CHOSEN by the North Carolina Biotechnology Center Board of Directors as the organization's new president and chief executive officer. Tolson, 67, who had served as secretary of three state cabinet departments, became the Biotechnology Center's interim ...
CIIT renamed for Hamner; will expand mission, facilities.
Jul 01, 2007 ... DR. CHARLES HAMNER OFFICIALLY RETIRED IN 2002 AFTER 14 YEARS as president and CEO of the North Carolina Biotechnology Center, but his work to build the state's bioscience community continues and his legacy grows. Hamner was honored June 7 at a ceremony in Research Triangle Park ...
Magazines laud N.C. economic development results.
Jul 01, 2007 ... The decision by Swiss drug maker Novartis to invest $267.5 million over five years in a new vaccine manufacturing plant in Holly Springs has been cited by Site Selection magazine as one of North America's top 20 economic development packages of the year. The plant is expected to ...
North Carolina biotech maintains No. 3 status nationally.
Jul 01, 2007 ... North Carolina has the nation's third largest biotechnology industry for the fourth consecutive year, according to the authors of major new study. Ernst & Young no longer ranks states in its annual biotechnology industry report, but if it did North Carolina would remain No. 3 ...
University of North Carolina.(PEOPLE)
Jul 01, 2007 ... Dr. Steven Leath, associate dean for research and director of the N.C. Agricultural Research Service at North Carolina State University, has been named vice president for research of the multi-campus University of North Carolina system. He succeeds Russ Lea, who ...
University of North Carolina-Chapel Hill.(PEOPLE)
Jul 01, 2007 ... Holden Thorp, distinguished professor and chair of the department of chemistry at the University of North Carolina-Chapel Hill, has been named dean of the College of Arts and Sciences. Thorp has published more than 120 scholarly publications on the electronic properties of DNA and ...
NCBIO.(PEOPLE)
Jul 01, 2007 ... NCBIO, North Carolina's biotechnology trade association, has appointed eight members to its board of directors, to serve three-year terms ending in 2010: Jonathan Bryant of BASF Plant Science; John Cox of Biogen ...
The Aurora Funds.(PEOPLE)
Jul 01, 2007 ... The Aurora Funds, a Research Triangle park-based seed- and early-stage venture capital firm, has promoted Chris Kroeger, M.D. and Grant Jackson to partnerships ....
Targacept.(PEOPLE)
Jul 01, 2007 ... Dr. Ralph Snyderman, former Ceo of the Duke University Health System and current Ceo ...
Expression Analysis.(PEOPLE)
Jul 01, 2007 ... Expression Analysis of Durham has hired C. Anne Pontius as senior director of quality systems. She ...
Trimeris.(PEOPLE)
Jul 01, 2007 ... Trimeris, of Morrisville, has appointed Stephen R. Davis and Barry D. Quart, Pharm. D. to the company's board of directors. Davis is executive vice president and chief operating officer of Neurogen. Quart is president and chief executive officer of Ardea Biosciences, Also on June 27, 2007, ...
Inspire Pharmaceuticals.(PEOPLE)
Jul 01, 2007 ... Stephen D. Celestini has joined Inspire Pharmaceuticals as senior vice president and chief compliance officer, reporting to Inspire's president and Ceo, Christy L. Shaffer, Ph.D. Celestini previously worked with Salix ...
Bioprocessing/Process Development (BPD) Group.(PEOPLE)
Jul 01, 2007 ... Tanya Scharton-Kersten, Ph.D., and Ruben Carbonell, Ph.D., have become chair and vice-chair of the Bioprocessing/ Process Development (BPD) Group, one of eight intellectual exchange organizations hosted by ...
Aldagen.(PEOPLE)
Jul 01, 2007 ... Aldagen of Durham has appointed Matthew E. Czajkowski as chief financial officer. He was previously chief financial officer and senior vice president of finance and administration at Pozen of Chapel Hill. Aldagen has also named Dr. Martin J. Murphy Jr. to its board ...
Biolex Therapeutics.(PEOPLE)
Jul 01, 2007 ... Sunny Sharma, M.D., vice president with Investor Growth Capital, ...
Erimos Pharmaceuticals.(PEOPLE)
Jul 01, 2007 ... Erimos Pharmaceuticals has named J. Scott Mohrland, Ph.D., president and Ceo ....
PPD.(PEOPLE)
Jul 01, 2007 ... PPD of Wilmington has named William J. Sharbaugh as its new chief operating officer. Sharbaugh comes to ppD ...
Serenex.(PEOPLE)
Jul 01, 2007 ... Serenex of Durham has appointed Judith C. Bryson, Pharm.D., vice president of clinical development ....
